Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified May 2014 by PATH
Sponsor:
Collaborators:
Bill and Melinda Gates Foundation
Information provided by (Responsible Party):
PATH
ClinicalTrials.gov Identifier:
NCT02165202
First received: May 21, 2014
Last updated: June 13, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: October 2016
  Estimated Primary Completion Date: October 2016 (Final data collection date for primary outcome measure)